Relapse

Roche, a Swiss multinational healthcare company, has announced its plans to submit a Marketing Authorization Application (MAA) for its drug,...

Cannabis use disorder (CUD) is a condition that affects individuals who use cannabis regularly. It is characterized by a range...

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system. It is characterized by inflammation, demyelination,...

Leukemia is a type of cancer that affects the blood and bone marrow, where the body produces blood cells. Chronic...

Teva’s Uzedy drug for schizophrenia has been making headlines recently due to its significant impact on reducing the risk of...

AstraZeneca’s Ultomiris has received extended authorization in the European Union (EU) for the treatment of a rare neurological condition called...